The Independent Pharmacy: UK's Pharmaceuticals & Medication Source

Category: Healthcare and Pharmaceuticals - Page 3

post-image
Dec, 23 2025

Generic Drug Recalls: Why They Happen and What to Do

Eldric Moreland
8
Generic drug recalls happen due to manufacturing flaws, contamination, or failed quality tests. Learn why they occur, how to check if your meds are affected, and what steps to take to stay safe.
post-image
Dec, 18 2025

How Generic Medicines Saved the U.S. Healthcare System Over $3.4 Trillion

Eldric Moreland
10
Generic and biosimilar drugs saved the U.S. healthcare system $467 billion in 2024 and over $3.4 trillion since 2015. Learn how these affordable medications cut costs, who benefits most, and why policy barriers still hold back even greater savings.
post-image
Dec, 17 2025

How FDA Ensures Generic Drug Quality During Manufacturing

Eldric Moreland
15
The FDA ensures generic drug quality through strict cGMP standards, unannounced inspections, and rigorous testing of every manufacturing step - not just the final product. This system keeps generics safe, effective, and affordable for millions.
post-image
Dec, 10 2025

Why Doctors Recommend Generic Medications - And Why Patients Still Hesitate

Eldric Moreland
15
Doctors recommend generics because they’re just as effective and save patients hundreds a year. But patient distrust and outdated beliefs still hold back adoption. Here’s why generics work - and how to get past the stigma.
post-image
Dec, 5 2025

International Pharmacovigilance: How Global Safety Monitoring Is Being Harmonized

Eldric Moreland
11
Global drug safety monitoring is becoming more aligned through ICH guidelines, AI, and shared data systems. Learn how harmonization speeds up safety alerts, cuts costs, and protects patients worldwide-even in low-resource countries.
post-image
Dec, 3 2025

Future Approaches to Changing Perceptions of Generic Drugs

Eldric Moreland
15
Generic drugs save billions annually but still face public distrust. Learn how new education strategies, biosimilars, and technology are reshaping perceptions and building trust in affordable medications.
post-image
Dec, 2 2025

Hospital Formularies: How Systems Choose Generic Drugs

Eldric Moreland
12
Hospital formularies use evidence-based processes to select generic drugs that balance safety, effectiveness, and cost. Learn how Pharmacy and Therapeutics committees make these critical decisions and why they matter for patient care.
post-image
Dec, 2 2025

What Are Authorized Generics? A Complete Breakdown of How They Work and Why They Matter

Eldric Moreland
10
Authorized generics are brand-name drugs sold without the brand name, made by the same manufacturer with identical ingredients. They offer lower prices while maintaining the exact formulation-unlike traditional generics. Learn how they work, why they exist, and how to get them.
post-image
Dec, 1 2025

FDA Listing for Biosimilars: How They Are Evaluated and Approved

Eldric Moreland
14
The FDA doesn't rate biosimilars like grades-they approve them through a strict scientific process to ensure they're highly similar to biologics with no clinically meaningful differences. Here's how it works, why they're not generics, and what you need to know about interchangeability.
post-image
Nov, 27 2025

Biologic Patent Protection: When Biosimilars Can Enter the U.S. Market

Eldric Moreland
11
Biologic patent protection in the U.S. gives drugmakers 12 years of exclusivity before biosimilars can enter, delaying affordable alternatives. Learn how the BPCIA, patent thickets, and global differences affect patient access and drug prices.

Categories

Latest Courses

Popular Tags